ArticleACS medicinal chemistry letters2025

Novel Heterocyclic Compounds as SMN2 Modulators for Treating Spinal Muscular Atrophy Via Modulation of SMN2 Splicing.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.